Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jul 30, 2021
Distillery Therapeutics

Inhibiting RPS6KA6 with floxacin antibiotics for bladder, lung cancers 

DISEASE CATEGORY: Cancer
INDICATION: Bladder cancer; lung cancer Derivatives of the antibiotics moxifloxacin and trovafloxacin and other inhibitors of RPS6KA6 could treat bladder and lung
Items per page:
1 - 1 of 1